Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
9.44B | 8.78B | 8.18B | 7.72B | 7.53B | 8.00B | Gross Profit |
377.25M | 575.98M | 482.25M | 412.57M | 278.40M | 487.52M | EBIT |
-57.64M | 163.51M | 53.67M | -47.84M | -160.77M | 54.86M | EBITDA |
13.28M | 361.29M | 135.68M | 38.76M | -39.04M | 141.17M | Net Income Common Stockholders |
-260.33M | 72.09M | 105.09M | 122.00M | -184.51M | 101.43M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.94B | 1.31B | 1.42B | 1.46B | 1.57B | 1.15B | Total Assets |
8.46B | 8.96B | 8.62B | 8.46B | 8.57B | 8.15B | Total Debt |
3.23B | 3.20B | 2.82B | 3.14B | 3.27B | 2.92B | Net Debt |
1.52B | 2.25B | 1.40B | 1.69B | 1.70B | 1.77B | Total Liabilities |
6.22B | 6.43B | 6.14B | 6.05B | 6.23B | 5.66B | Stockholders Equity |
2.22B | 2.46B | 2.44B | 2.38B | 2.29B | 2.46B |
Cash Flow | Free Cash Flow | ||||
-14.85M | -632.71M | -23.20M | -132.14M | 72.16M | -1.02B | Operating Cash Flow |
655.00K | -629.01M | -5.52M | -113.96M | 172.49M | -683.59M | Investing Cash Flow |
-9.72M | 94.67M | 219.25M | 163.54M | 84.06M | -217.34M | Financing Cash Flow |
375.57M | 75.14M | -222.40M | -167.90M | 175.59M | 210.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | £155.55B | 10.37 | 10.33% | 6.07% | -3.40% | -7.51% | |
79 Outperform | $487.19B | 34.38 | 27.96% | 2.42% | 19.20% | 24.01% | |
70 Outperform | $99.81B | 6.50 | 15.59% | 5.72% | 1.89% | 29.67% | |
67 Neutral | HK$696.81B | 10.98 | 9.95% | -7.72% | -26.66% | ||
64 Neutral | $4.36B | 12.05 | 5.23% | 249.94% | 4.13% | -10.23% | |
59 Neutral | HK$50.81B | 12.43 | 9.94% | 5.76% | 1.39% | -21.74% | |
56 Neutral | HK$834.66M | ― | -11.14% | 4.84% | 20.89% | -296.52% |